Previous Close | 111.60 |
Open | 112.11 |
Bid | 0.00 x 800 |
Ask | 115.62 x 800 |
Day's Range | 110.70 - 112.58 |
52 Week Range | 74.69 - 116.04 |
Volume | |
Avg. Volume | 2,410,457 |
Market Cap | 27.373B |
Beta (5Y Monthly) | 0.69 |
PE Ratio (TTM) | 44.66 |
EPS (TTM) | 2.52 |
Earnings Date | May 02, 2024 |
Forward Dividend & Yield | 2.00 (1.78%) |
Ex-Dividend Date | Mar 28, 2024 |
1y Target Est | 115.29 |
Subscribe to Yahoo Finance Plus to view Fair Value for CAH
Accuray (ARAY) announces the latest data that supports the use of its CyberKnife System in the treatment of recurrent prostate cancer with stereotactic body radiation therapy.
Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.
Investors are optimistic about DexCom's (DXCM) strong product portfolio.